BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $764,000 | -21.5% | 14,180 | -6.4% | 0.04% | -21.7% |
| Q2 2022 | $973,000 | -20.9% | 15,142 | -4.6% | 0.05% | -13.2% |
| Q1 2022 | $1,230,000 | -15.2% | 15,866 | -6.1% | 0.05% | -24.3% |
| Q4 2021 | $1,450,000 | +3.0% | 16,895 | -3.5% | 0.07% | -10.3% |
| Q3 2021 | $1,408,000 | -3.6% | 17,500 | -3.6% | 0.08% | -7.1% |
| Q2 2021 | $1,461,000 | -10.7% | 18,155 | -6.4% | 0.08% | -25.0% |
| Q1 2021 | $1,636,000 | -3.3% | 19,400 | -8.0% | 0.11% | -7.4% |
| Q4 2020 | $1,692,000 | -2.6% | 21,084 | -2.4% | 0.12% | -12.9% |
| Q3 2020 | $1,737,000 | -5.7% | 21,594 | +1.0% | 0.14% | -10.3% |
| Q2 2020 | $1,842,000 | +12.1% | 21,390 | +5.7% | 0.16% | -1.9% |
| Q1 2020 | $1,643,000 | -0.8% | 20,241 | +2.2% | 0.16% | +24.4% |
| Q4 2019 | $1,656,000 | -3.0% | 19,806 | +1.5% | 0.13% | -9.9% |
| Q3 2019 | $1,707,000 | +6.0% | 19,510 | -0.7% | 0.14% | +6.0% |
| Q2 2019 | $1,610,000 | -5.9% | 19,655 | -11.4% | 0.13% | -10.7% |
| Q3 2018 | $1,711,000 | +4.0% | 22,190 | -0.4% | 0.15% | -2.6% |
| Q2 2018 | $1,645,000 | +11.1% | 22,280 | -2.2% | 0.15% | +10.1% |
| Q1 2018 | $1,481,000 | +0.7% | 22,770 | +0.0% | 0.14% | +4.5% |
| Q4 2017 | $1,471,000 | -2.9% | 22,762 | -5.7% | 0.13% | -13.6% |
| Q3 2017 | $1,515,000 | +9.7% | 24,143 | +5.8% | 0.15% | +6.2% |
| Q2 2017 | $1,381,000 | +14.6% | 22,816 | -1.8% | 0.14% | +13.3% |
| Q1 2017 | $1,205,000 | +14.0% | 23,227 | -2.6% | 0.13% | +8.5% |
| Q4 2016 | $1,057,000 | -3.8% | 23,841 | +3.2% | 0.12% | -7.8% |
| Q3 2016 | $1,099,000 | +9.6% | 23,093 | +4.1% | 0.13% | +6.7% |
| Q2 2016 | $1,003,000 | +9.0% | 22,183 | -1.0% | 0.12% | +5.3% |
| Q1 2016 | $920,000 | +7.4% | 22,398 | -0.3% | 0.11% | +5.6% |
| Q4 2015 | $857,000 | +11.4% | 22,463 | -4.0% | 0.11% | +2.9% |
| Q3 2015 | $769,000 | -53.5% | 23,401 | -1.1% | 0.10% | -49.5% |
| Q2 2015 | $1,654,000 | +0.2% | 23,656 | -1.8% | 0.21% | +1.0% |
| Q1 2015 | $1,650,000 | -9.1% | 24,083 | -2.7% | 0.21% | -8.8% |
| Q4 2014 | $1,815,000 | +2.7% | 24,758 | +0.6% | 0.23% | -3.0% |
| Q3 2014 | $1,767,000 | -3.1% | 24,618 | -2.4% | 0.23% | -1.3% |
| Q2 2014 | $1,824,000 | -3.0% | 25,226 | -1.3% | 0.24% | -4.8% |
| Q1 2014 | $1,880,000 | +7.2% | 25,556 | +1.3% | 0.25% | +0.4% |
| Q4 2013 | $1,754,000 | +3.9% | 25,216 | -1.9% | 0.25% | -6.4% |
| Q3 2013 | $1,688,000 | -5.3% | 25,696 | -0.1% | 0.26% | -11.1% |
| Q2 2013 | $1,782,000 | – | 25,728 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 298,721 | $23,969,000 | 8.70% |
| GENERATION INVESTMENT MANAGEMENT LLP | 17,424,560 | $1,398,147,000 | 6.24% |
| Soditic Asset Management LLP | 77,950 | $6,255,000 | 6.24% |
| Veritas Asset Management LLP | 11,110,132 | $891,477,000 | 5.32% |
| Dash Acquisitions Inc. | 84,560 | $6,785,000 | 4.74% |
| Prosight Management, LP | 121,075 | $9,715,000 | 4.49% |
| TSFG, LLC | 94,977 | $7,621,000 | 4.07% |
| CINCINNATI FINANCIAL CORP | 1,344,648 | $107,895,000 | 2.93% |
| Dundas Partners LLP | 204,535 | $19,304,000 | 2.82% |
| Unified Trust Company, N.A. | 59,491 | $4,689,000 | 2.72% |